Surgical Outcome of Hilar Plate Resection: Extended Hilar Bile Duct Resection Without Hepatectomy

详细信息    查看全文

• 作者：Takehiro Noji (1)
  Takahiro Tsuchikawa (1)
  Keisuke Okamura (1)
  Toshiaki Shichinohe (1)
  Eiichi Tanaka (1)
  Satoshi Hirano (1)
  
• 关键词：Hilar bile duct resection ; Hepatectomy ; Cholangiocarcinoma ; Palliative surgery
• 刊名：Journal of Gastrointestinal Surgery
• 出版年：2014
• 出版时间：June 2014
• 年：2014
• 卷：18
• 期：6
• 页码：1131-1137
• 全文大小：
• 参考文献：1. Kondo S, Hirano S, Ambo Y, Tanaka E, Okushiba S, Morikawa T, et al. Forty consecutive resections of hilar cholangiocarcinoma with no postoperative mortality and no positive ductal margins: results of a prospective study. Annals of surgery. 2004;240(1):95-101. Epub 2004/06/24. CrossRef
  2. Hirano S, Kondo S, Tanaka E, Shichinohe T, Tsuchikawa T, Kato K, et al. Outcome of surgical treatment of hilar cholangiocarcinoma: a special reference to postoperative morbidity and mortality. Journal of hepato-biliary-pancreatic surgery. 2009;17(4):455-62. Epub 2009/10/13. CrossRef
  3. Hirano S, Kondo S, Tanaka E, Shichinohe T, Tsuchikawa T, Kato K. No-touch resection of hilar malignancies with right hepatectomy and routine portal reconstruction. Journal of hepato-biliary-pancreatic surgery. 2009;16(4):502-7. Epub 2009/04/11. CrossRef
  4. Miyazaki M, Kimura F, Shimizu H, Yoshidome H, Otuka M, Kato A, et al. One hundred seven consecutive surgical resections for hilar cholangiocarcinoma of Bismuth types II, III, IV between 2001 and 2008. Journal of hepato-biliary-pancreatic sciences. 2010;17(4):470-5. Epub 2009/11/26. CrossRef
  5. Nagino M, Ebata T, Yokoyama Y, Igami T, Sugawara G, Takahashi Y, et al. Evolution of Surgical Treatment for Perihilar Cholangiocarcinoma: A Single-Center 34-Year Review of 574 Consecutive Resections. Annals of surgery. 2012. Epub 2012/10/13.
  6. Seyama Y, Kubota K, Sano K, Noie T, Takayama T, Kosuge T, et al. Long-term outcome of extended hemihepatectomy for hilar bile duct cancer with no mortality and high survival rate. Annals of surgery. 2003;238(1):73-83. Epub 2003/07/02.
  7. Kosuge T, Yamamoto J, Shimada K, Yamasaki S, Makuuchi M. Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection. Annals of surgery. 1999;230(5):663-71. Epub 1999/11/24. CrossRef
  8. Shimada H, Endo I, Fujii Y, Kunihiro O, Tanaka K, Misuta K, et al. Procedure of extended hilar bile duct resection and its application for hilar cholangiocarcinoma. Hepato-gastroenterology. 2002;49(44):300-5. Epub 2002/05/09.
  9. Miyazaki M, Ito H, Nakagawa K, Ambiru S, Shimizu H, Okaya T, et al. Parenchyma-preserving hepatectomy in the surgical treatment of hilar cholangiocarcinoma. Journal of the American College of Surgeons. 1999;189(6):575-83. Epub 1999/12/10. CrossRef
  10. Shimada H, Endo I, Sugita M, Masunari H, Fujii Y, Tanaka K, et al. Is parenchyma-preserving hepatectomy a noble option in the surgical treatment for high-risk patients with hilar bile duct cancer? Langenbeck’s archives of surgery / Deutsche Gesellschaft fur Chirurgie. 2003;388(1):33-41. Epub 2003/04/12.
  11. Kawarada Y, Das BC, Naganuma T, Tabata M, Taoka H. Surgical treatment of hilar bile duct carcinoma: experience with 25 consecutive hepatectomies. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 2002;6(4):617-24. Epub 2002/07/20. CrossRef
  12. Nakanishi Y, Zen Y, Kawakami H, Kubota K, Itoh T, Hirano S, et al. Extrahepatic bile duct carcinoma with extensive intraepithelial spread: a clinicopathological study of 21 cases. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2008;21(7):807-16. Epub 2008/04/22. CrossRef
  13. Ikeyama T, Nagino M, Oda K, Ebata T, Nishio H, Nimura Y. Surgical approach to bismuth Type I and II hilar cholangiocarcinomas: audit of 54 consecutive cases. Annals of surgery. 2007;246(6):1052-7. Epub 2007/11/29. CrossRef
  14. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. American journal of clinical oncology. 1982;5(6):649-55. Epub 1982/12/01. CrossRef
  15. Hirano S, Tanaka E, Shichinohe T, Suzuki O, Hazama K, Kitagami H, et al. Treatment strategy for hilar cholangiocarcinoma, with special reference to the limits of ductal resection in right-sided hepatectomies. Journal of hepato-biliary-pancreatic surgery. 2007;14(5):429-33. Epub 2007/10/03. CrossRef
  16. Masunari H, Shimada H, Endo I, Fujii Y, Tanaka K, Sekido H, et al. Surgical anatomy of hepatic hilum with special reference of the plate system and extrahepatic duct. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 2008;12(6):1047-53. Epub 2007/10/17. CrossRef
  17. Hirano S, Tanaka E, Tsuchikawa T, Matsumoto J, Shichinohe T, Kato K. Techniques of biliary reconstruction following bile duct resection (with video). Journal of hepato-biliary-pancreatic sciences. 2012;19(3):203-9. Epub 2011/11/15. CrossRef
  18. Noji T, Miyamoto M, Kubota KC, Shinohara T, Ambo Y, Matsuno Y, et al. Evaluation of extra capsular lymph node involvement in patients with extra-hepatic bile duct cancer. World journal of surgical oncology. 2012;10:106. Epub 2012/06/12. CrossRef
  19. Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Annals of surgical oncology. 2010;17(6):1471-4. Epub 2010/02/25. CrossRef
  20. Surgery JSoB. Classification of Biliary Tract Carcinoma Second English Edition. 2nd edition ed: Kanehara Co.,LTD., Tokyo; 2001 2001/04/13.
  21. Hirano S, Kondo S, Tanaka E, Shichinohe T, Tsuchikawa T, Kato K. Safety of combined resection of the middle hepatic artery in right hemihepatectomy for hilar biliary malignancy. Journal of hepato-biliary-pancreatic surgery. 2009;16(6):796-801. Epub 2009/04/24. CrossRef
  22. Nagino M. Perihilar cholangiocarcinoma: a surgeon’s viewpoint on current topics. Journal of gastroenterology. 2012;47(11):1165-76. Epub 2012/08/01. CrossRef
  23. Hidalgo E, Asthana S, Nishio H, Wyatt J, Toogood GJ, Prasad KR, et al. Surgery for hilar cholangiocarcinoma: the Leeds experience. Eur J Surg Oncol. 2008;34(7):787-94. Epub 2007/11/27. CrossRef
  24. Ebata T, Yokoyama Y, Igami T, Sugawara G, Takahashi Y, Nimura Y, et al. Hepatopancreatoduodenectomy for cholangiocarcinoma: a single-center review of 85 consecutive patients. Annals of surgery. 2012;256(2):297-305. Epub 2012/07/04. CrossRef
  25. Miyazaki M, Kimura F, Shimizu H, Yoshidome H, Otuka M, Kato A, et al. One hundred seven consecutive surgical resections for hilar cholangiocarcinoma of Bismuth types II, III, IV between 2001 and 2008. Journal of hepato-biliary-pancreatic surgery. 2009. Epub 2009/11/26.
  26. Aydin U, Yedibela S, Yazici P, Aydinli B, Zeytunlu M, Kilic M, et al. A new technique of biliary reconstruction after "high hilar resection" of hilar cholangiocarcinoma with tumor extension to secondary and tertiary biliary radicals. Annals of surgical oncology. 2008;15(7):1871-9. Epub 2008/05/06. CrossRef
  
• 作者单位：Takehiro Noji (1)
  Takahiro Tsuchikawa (1)
  Keisuke Okamura (1)
  Toshiaki Shichinohe (1)
  Eiichi Tanaka (1)
  Satoshi Hirano (1)
  
  1. Department of Gastroenterological Surgery II, Hokkaido University Graduate School of Medicine, Kita 15 Nishi 7, Kita-ku, Sapporo, Hokkaido, 0608638, Japan
  
• ISSN：1873-4626

文摘

Background We have done curative or palliative extended extrahepatic bile duct resection at the level of the hilar plate for selected patients with cholangiocarcinoma with hilar spreading, calling this procedure “hilar plate resection-(HPR), but the results of evaluating the clinical benefits of HPR for cholangiocarcinoma with hilar spreading have not been reported. Patients and Methods Fifty-two patients with cholangiocarcinoma underwent HPR: the curative procedure was performed in 28 patients (cHPR group) and the palliative in 24 patients (pHPR group). In the same period, 128 patients with cholangiocarcinoma underwent major hepatectomy with intrahepatic cholangiojejunostomy (Hx group). These groups were compared in terms of post-operative complications and survival. Results There were no significant differences in the rate of patients with post-operative complications and in post-operative hospital stay. The overall cumulative 5-year survival rates for each procedure (Hx group, cHPR group and pHPR group) were 40, 38 and 11?%, respectively. There was no significant difference between the Hx and cHPR groups in survival rates (p--.87). Conclusion In conclusion, HPR appears to be safe and feasible for selected patients with cholangiocarcinoma. However, the indications for HPR should be restricted.